UT Health San Antonio awarded $1.8 million NIH grant for research in addiction recovery support services

December 13, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 13, 2022 – With the U.S. grappling with an unprecedented opioid-related overdose crisis, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded a $1.8 million grant from the National Institutes of Health to research peer recovery support services for […]




National Academy of Inventors to induct Jean Jiang, PhD, of UT Health San Antonio

December 12, 2022

Studies of cell channels lead to therapeutic antibodies in clinical trials Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 12, 2022) — Jean X. Jiang, PhD, whose pioneering research has given rise to potential bone cancer and brain injury therapeutics currently under evaluation in clinical trials, will be inducted as a Fellow of the National […]

Jean Jiang, Ph.D., lab


A record-breaking year for UT Health San Antonio School of Dentistry’s research program

December 8, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Dec. 8, 2022 – The UT Health San Antonio School of Dentistry secured nearly $35 million in total research grants awarded during its 2022 fiscal year, which ended Aug. 31, setting a new record for the school’s research program. “Our school’s research mission focuses on finding solutions to […]




Be Well Texas, Hill Country MHDD Centers join to offer substance use care for Uvalde residents

December 7, 2022

UT Health San Antonio contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Hill Country MHDD contact: Kelsi Wilmot, 830-370-6302, kelsi8310@hillcountry.org SAN ANTONIO, Dec. 7, 2022 – Be Well Texas, a statewide initiative of UT Health San Antonio, and Hill Country Mental Health & Developmental Disabilities Centers have entered into an agreement to provide substance use disorder (SUD) treatment […]





Can Alzheimer’s disease be delayed or stopped before the symptoms begin? A new clinical trial strives to find answers.

December 1, 2022

The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 1, 2022) — The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, part of The University of Texas […]

Alzheimer's Disease